Rankings
▼
Calendar
CAMP Q2 2018 Earnings — CAMP4 Therapeutics Corporation Revenue & Financial Results | Market Cap Arena
CAMP
CAMP4 Therapeutics Corporation
$126M
Q2 2018 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$95M
+7.7% YoY
Gross Profit
$38M
40.1% margin
Operating Income
-$574,000
-0.6% margin
Net Income
$9M
9.0% margin
EPS (Diluted)
$0.23
QoQ Revenue Growth
+0.5%
Cash Flow
Operating Cash Flow
$31M
Free Cash Flow
$29M
Stock-Based Comp.
$2M
Balance Sheet
Total Assets
$493M
Total Liabilities
$291M
Stockholders' Equity
$202M
Cash & Equivalents
$170M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$95M
$88M
+7.7%
Gross Profit
$38M
$37M
+1.7%
Operating Income
-$574,000
-$1M
+56.8%
Net Income
$9M
-$3M
+420.7%
Revenue Segments
Telematics Systems
$76M
80%
Software And Subscription Services
$19M
20%
Geographic Segments
UNITED STATES
$70M
74%
Europe Middle East And Africa
$13M
14%
South America
$4M
4%
Asia Pacific
$4M
4%
All Other
$2M
2%
CANADA
$1M
1%
← FY 2018
All Quarters
Q3 2018 →